Abbott Laboratories vs. Atea Pharmaceuticals, Inc. Common Stock
Abbott Laboratories and Atea Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | AVIR | |
|---|---|---|
| Market Cap | $186.81 billion | $399.34 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | AVIR | |
|---|---|---|
| Dividend Yield | 2.33% | — |
ABT and AVIR split the dividend factors evenly.
Risk & Sentiment
| ABT | AVIR | |
|---|---|---|
| Short Interest | 0.57% | 0.39% |
AVIR leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, AVIR overview, AVIR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.